Since 1995 Paul Larocque has been the President of Acerna Inc. He has experience in both industry and government having held senior GMP and regulatory positions with Pfizer, SmithKline/Allergan, Eldan, and Health Canada.
He has served on or chaired a number of trade association boards or committees including being the head of the Rx&D committee that negotiated the Canadian GMP Guideline, 3rd edition, which added the Sterile Products chapter and edited most other chapters. He has twice been elected Chair of the Canadian Association of Professionals in Regulatory Affairs - Association canadienne des professionnels en réglementation.
After graduation from university he earned his Chartered Chemist designation from the Association of the Chemical Profession of Ontario.
Biographies of our other consultants will be provided on request.